FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039808 [Registered on: 28/01/2022] Trial Registered Prospectively
Last Modified On: 29/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Quality of life of Uthiravatha suronitham(Rheumatoid arthritis) 
Scientific Title of Study   AN ASSESSMENT OF QUALITY OF LIFE IN UTHIRAVATHA SURONITHAM(RHEUMATOID ARTHRITIS)PATIENTS REPORTING AT AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA A CROSS SECTIONAL STUDY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr A Surya 
Designation  PG Scholar 
Affiliation  National Institute of siddha  
Address  Room 1 Department of Maruthuvam National Institute of Siddha Tambaram sanatorium Kancheepuram chennai 600047
Room 1 Department of Maruthuvam National institute of Siddha Tambaram sanatorium kancheepuram chennai 600047
Kancheepuram
TAMIL NADU
600047
India 
Phone  8072897366  
Fax  22381314  
Email  suryaasaithambi1995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr H Nalini sofia 
Designation  Associate proffessor 
Affiliation  National Institute of siddha  
Address  Room 1 Department of Maruthuvam National Institute of Siddha Tambaram sanatorium Kancheepuram chennai 600047
Room 1 Department of Maruthuvam National institute of Siddha Tambaram sanatorium kancheepuram chennai 600047
Kancheepuram
TAMIL NADU
600047
India 
Phone  8939899363  
Fax  22381314  
Email  dr.h.nalinisofia@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr A Surya 
Designation  PG Scholar 
Affiliation  National Institute of siddha  
Address  Room 1 Department of Maruthuvam National Institute of Siddha Tambaram sanatorium Kancheepuram chennai 600047
Room 1 Department of Maruthuvam National institute of Siddha Tambaram sanatorium kancheepuram chennai 600047
Kancheepuram
TAMIL NADU
600047
India 
Phone  8072897366  
Fax  22381314  
Email  suryaasaithambi1995@gmail.com  
 
Source of Monetary or Material Support  
NATIONAL INSTITUTE OF SIDDHA 
 
Primary Sponsor  
Name  National Institute of Siddha 
Address  Room 1 Department of Maruthuvam National Institute of Siddha Tambaram sanatorium 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr A Surya  AYOTHIDOSS PANDITHAR HOSPITAL  Room no 1 Department of Maruthuvam National Institute of Siddha Tambaram sanatorium
Kancheepuram
TAMIL NADU 
8072897366
22381314
suryaasaithambi1995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M256||Stiffness of joint, not elsewhereclassified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Age 30 TO 65 Years Male Female and Transgender K/C/O Uthiravatha suronitham(Rheumatoid Arthritis)patients
with sero negative sero positive RA Lab investigations patients who are willing to give informed consent  
 
ExclusionCriteria 
Details  Age below 30 and above 65 years Patients with normal CRP Anti CCP test results Patient who are not willing to give consent form Patients defects (Osteoarthritis Psoriatic arthritis Gout arthritis) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham  6months 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  Six months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "100"
Final Enrollment numbers achieved (India)="100" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/02/2022 
Date of Study Completion (India) 20/04/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Rheumatoid arthritis is the most common persistent inflammatory arthritis. The symptoms are pain, joint swelling and stiffness affecting the small joints of the hand, feet, and wrists. Large joint involvement, systemic symptoms and extra articular features may also occur. OBJECTIVE: To estimate the quality of life (QOL) in Uthiravatha suronitham patients reporting at OPD of Ayothidoss Pandithar hospital, NIS through Rheumatoid Arthritis Flare Questionnaire (RA-FQ) and to assess the predisposing factors of Uthiravatha suronitham with respect age, gender, chronicity of illness, personal history, occupational history, family history, stress etc. MATERIALS AND METHODS: This is a Hospital based cross sectional study, included 100  Uthiravatha suronitham patients reported OPD of ayothidoss pandithar hospital were  enrolled  based on inclusion  and exclusion criteria. After obtaining informed consent form, data were collected by using  Rheumatoid Arthritis Flare Questionnaire (RA-FQ) and Beck’s Depression Inventory form to estimate the quality of life. RESULTS : In 100 Uthiravatha suronitham patients, over all  score is 42.9 in  RA-FQ (Maximum 50) questionnaire. In beck’s depression Inventory showed that  38% patients had Moderate depression and 33% patients had Severe depression. CONCLUSION: Rheumatoid arthritis significantly affects the quality of life of patients both physically and mentally.  
Close